These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 6337307)
21. [Broth microdilution test for the standardized determination of minimal inhibitory and minimal bactericidal concentrations of antimicrobial drugs in rapidly growing aerobic bacteria]. Klare I; Witte W Z Gesamte Hyg; 1988 Feb; 34(2):111-5. PubMed ID: 3369199 [No Abstract] [Full Text] [Related]
22. Pharmacodynamics of antimicrobial agents. Bactericidal and postantibiotic effects. Levison ME Infect Dis Clin North Am; 1995 Sep; 9(3):483-95. PubMed ID: 7490429 [TBL] [Abstract][Full Text] [Related]
23. [Beta-lactam resistance in aquatic Enterobacter cloacae strains using phenotypic and genotypic criteria]. Lazăr V; Cernat R; Balotescu C; Cotar A; Coipan E; Cojocaru C Bacteriol Virusol Parazitol Epidemiol; 2002; 47(3-4):185-91. PubMed ID: 15085610 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of antimicrobial susceptibility testing of bacterial mixtures using agar dilution technique. Athar MA Am J Med Technol; 1980 Feb; 46(2):85-90. PubMed ID: 6986770 [TBL] [Abstract][Full Text] [Related]
25. In vitro testing of antimicrobial agents. Washington JA Infect Dis Clin North Am; 1989 Sep; 3(3):375-87. PubMed ID: 2671127 [TBL] [Abstract][Full Text] [Related]
26. [In vitro activity of 9 antibiotics and 3 beta-lactamase inhibitors against 107 clinical isolates of Acinetobacter baumanii]. Echeverría MJ; López de Goicoechea MJ; Ayarza R; Vecino Y; Lazpita MA; Ibarretxebea AB; Barbier A; Cruz González M; Martínez de la Fuente P Enferm Infecc Microbiol Clin; 1997; 15(6):319-22. PubMed ID: 9376404 [TBL] [Abstract][Full Text] [Related]
27. Bacteriologic features and antimicrobial susceptibility in isolates from orofacial odontogenic infections. Kuriyama T; Karasawa T; Nakagawa K; Saiki Y; Yamamoto E; Nakamura S Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Nov; 90(5):600-8. PubMed ID: 11077383 [TBL] [Abstract][Full Text] [Related]
28. Clinical limitations of in vitro testing of microorganism susceptibility. Nightingale J Am J Hosp Pharm; 1987 Jan; 44(1):131-7. PubMed ID: 3826085 [TBL] [Abstract][Full Text] [Related]
30. Antibacterial and antifungal activities of extracts of combretum molle. Asres K; Mazumder A; Bucar F Ethiop Med J; 2006 Jul; 44(3):269-77. PubMed ID: 17447394 [TBL] [Abstract][Full Text] [Related]
31. New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach. Blondeau JM Vet Dermatol; 2009 Oct; 20(5-6):383-96. PubMed ID: 20178475 [TBL] [Abstract][Full Text] [Related]
32. Comparison of E-test with other conventional susceptibility testing methods for ciprofloxacin and gentamicin against gram negative enteric bacilli. Ogbolu DO; Terry-Alli OA; Daini OA; Olabiyi FA; Igharo EA Afr J Med Med Sci; 2012 Jun; 41(2):135-40. PubMed ID: 23185910 [TBL] [Abstract][Full Text] [Related]
33. Susceptibilities to 23 antimicrobial agents and beta-lactamase production of blood culture isolates of Acinetobacter sp in Hong Kong. Ling JM; Ng TK; Cheng AF; Norrby SR Scand J Infect Dis Suppl; 1996; 101():21-5. PubMed ID: 9060048 [TBL] [Abstract][Full Text] [Related]
34. [Prospective considerations on the dose-effect relationship in antibiotic therapy]. Yourassowsky E Ann Biol Clin (Paris); 1988; 46(2):138-43. PubMed ID: 3382064 [TBL] [Abstract][Full Text] [Related]
35. [Antimicrobial resistance and existence of metallo-beta-lactamase in Acinetobacter species isolated from adult patients]. Eser OK; Ergin A; Hasçelik G Mikrobiyol Bul; 2009 Jul; 43(3):383-90. PubMed ID: 19795613 [TBL] [Abstract][Full Text] [Related]
36. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains]. Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651 [TBL] [Abstract][Full Text] [Related]
37. [Identification of anaerobic bacteria isolated from various clinical specimens and determination of antibiotic susceptibilities]. Doğan M; Baysal B Mikrobiyol Bul; 2010 Apr; 44(2):211-9. PubMed ID: 20549955 [TBL] [Abstract][Full Text] [Related]
38. The bactericidal activity in serum and its prognostic clinical value. Klastersky J Infection; 1983; 11 Suppl 2():S93-6. PubMed ID: 6368398 [TBL] [Abstract][Full Text] [Related]
39. Antimicrobial synergy testing based on antibiotic levels, minimal bactericidal concentration, and serum bactericidal activity. Robinson A; Bartlett RC; Mazens MF Am J Clin Pathol; 1985 Sep; 84(3):328-33. PubMed ID: 4036862 [TBL] [Abstract][Full Text] [Related]
40. Considerations about the relationship of inhibitory concentrations and the pharmacologic and toxic properties of antimicrobial agents. Neu HC Diagn Microbiol Infect Dis; 1983 Mar; 1(1):41-7. PubMed ID: 6671364 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]